BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 10101376)

  • 1. Recent developments in maintenance prescribing and monitoring in the United Kingdom.
    Brewer C
    Bull N Y Acad Med; 1995; 72(2):359-70. PubMed ID: 10101376
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Harm reduction in Bern: from outreach to heroin maintenance.
    Haemmig RB
    Bull N Y Acad Med; 1995; 72(2):371-9. PubMed ID: 10101377
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prescribing heroin.
    Carnwath T
    Am J Addict; 2005; 14(4):311-8. PubMed ID: 16188711
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Feasibility of prescribing injectable heroin and methadone to opiate-dependent drug users: associated health gains and harm reductions.
    Metrebian N; Shanahan W; Wells B; Stimson GV
    Med J Aust; 1998 Jun; 168(12):596-600. PubMed ID: 9673620
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association between availability of heroin and methadone and fatal poisoning in England and Wales 1993-2004.
    Morgan O; Griffiths C; Hickman M
    Int J Epidemiol; 2006 Dec; 35(6):1579-85. PubMed ID: 17077102
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dosage regimes in the prescription of heroin and other narcotics to chronic opioid addicts in Switzerland--Swiss national cohort study.
    Gschwend P; Rehm J; Blättler R; Steffen T; Seidenberg A; Christen S; Bürki C; Gutzwiller F
    Eur Addict Res; 2004; 10(1):41-8. PubMed ID: 14665805
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Use of a new drug in the treatment of heroin addicts should not be obstructed by political dogmatism].
    Heilig M; Nilsson LH; Grönbladh L; Thulin SO; Sternebring B
    Lakartidningen; 2001 Sep; 98(37):3956-8. PubMed ID: 11586837
    [No Abstract]   [Full Text] [Related]  

  • 8. Divergent illicit drug policies in Europe.
    Ann Oncol; 1998 Dec; 9(12):1257. PubMed ID: 10232889
    [No Abstract]   [Full Text] [Related]  

  • 9. Injectable methadone prescribing in the United Kingdom--current practice and future policy guidelines.
    Sarfraz A; Alcorn RJ
    Subst Use Misuse; 1999 Oct; 34(12):1709-21. PubMed ID: 10499416
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Heroin prescription and history.
    Berridge V
    N Engl J Med; 2009 Aug; 361(8):820-1. PubMed ID: 19692694
    [No Abstract]   [Full Text] [Related]  

  • 11. Non-prescribed drug use during methadone treatment by clinic- and community-based patients.
    Wolff K; Hay AW; Vail A; Harrison K; Raistrick D
    Addiction; 1996 Nov; 91(11):1699-704. PubMed ID: 8972927
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prohibition of take-home dosages: negative consequences on methadone maintenance treatment.
    Pani PP; Pirastu R; Ricci A; Gessa GL
    Drug Alcohol Depend; 1996 May; 41(1):81-4. PubMed ID: 8793314
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prescribing drug of choice to illicit heroin users: the experience of a U.K. community drug team.
    McCusker C; Davies M
    J Subst Abuse Treat; 1996; 13(6):521-31. PubMed ID: 9219151
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Heroin maintenance and heroin control.
    Lidz CW
    Int J Addict; 1975; 10(1):35-52. PubMed ID: 1126768
    [No Abstract]   [Full Text] [Related]  

  • 15. Matching of treatment-resistant heroin-dependent patients to medical prescription of heroin or oral methadone treatment: results from two randomized controlled trials.
    Blanken P; Hendriks VM; Koeter MW; van Ree JM; van den Brink W
    Addiction; 2005 Jan; 100(1):89-95. PubMed ID: 15598196
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Dutch research on the effectiveness of medical prescription of heroin; background, research design and preliminary results].
    van den Brink W; Hendriks VM; Blanken P; van Ree JM
    Ned Tijdschr Geneeskd; 2000 Jan; 144(3):108-12. PubMed ID: 10674115
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Work and the journey to recovery: exploring the implications of welfare reform for methadone maintenance clients.
    Monaghan M; Wincup E
    Int J Drug Policy; 2013 Nov; 24(6):e81-6. PubMed ID: 24360401
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The use of levo-alpha-acetylmethadol (LAAM) in methadone patients who have not achieved heroin abstinence.
    Borg L; Ho A; Wells A; Joseph H; Appel P; Moody D; Kreek MJ
    J Addict Dis; 2002; 21(3):13-22. PubMed ID: 12094997
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Patients receiving a prescription for diamorphine (heroin) in the United Kingdom.
    Metrebian N; Carnwath Z; Mott J; Carnwath T; Stimson GV; Sell L
    Drug Alcohol Rev; 2006 Mar; 25(2):115-21. PubMed ID: 16627300
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The heroin prescribing debate: integrating science and politics.
    Bammer G; Dobler-Mikola A; Fleming PM; Strang J; Uchtenhagen A
    Science; 1999 May; 284(5418):1277-8. PubMed ID: 10383306
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.